Back to Results
First PageMeta Content
Medicine / Medicare Part D / Formulary / Medicare / Pharmaceutical policy / Pharmaceuticals policy / Health / Healthcare reform in the United States


New Benefit Designs in Exchange Plans Make Determining Out-of-Pocket Costs for Specialty Drugs Challenging Determining the cost or co-payment of a specialty drug—high-cost drugs typically used to treat complex diseases
Add to Reading List

Document Date: 2015-01-13 17:25:12


Open Document

File Size: 87,97 KB

Share Result on Facebook

City

Washington / D.C. / /

Company

Avalere Health LLC / /

IndustryTerm

HealthCare.gov enrollees / healthcare problems / business intelligence tools / actionable insights / healthcare / in-house analytic research / overall healthcare costs / manual search / /

MedicalCondition

cancer / rheumatoid arthritis / complex diseases / /

Organization

OMB / Congress / federal government / CMS / CBO / Medicare / /

Person

Caroline Pearson / Dan Mendelson / /

Position

CEO / Vice President / /

Technology

business intelligence / /

SocialTag